Company / Operating Cash Flow per Share
Organon & Co. Operating Cash Flow per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$2.72
FY2025
5-year range
$2.72 / $11.91
FY2021-FY2025
Trend
-26.1%
vs FY2024
Sector context
#36 of 212
Health Care
What the data says
Organon & Co.'s operating cash flow per share of $2.72 is higher than 83% of companies in the Health Care sector (FY2025). Operating Cash Flow per Share has fluctuated over the past 7 years, ranging from $2.72 in FY2025 to $11.91 in FY2019.
Based on SEC 10-K filings.
2.72 in FY2025 with a 5-year CAGR of -21.3%. Top quartile in the Health Care sector.
Declined from $3.14 to $2.72 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -7.1%
- 5-Year CAGR
- -21.3%
- 10-Year CAGR
- -
Sector benchmark
-48.5% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 26.1% year-over-year.
- Ranks #36 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.69 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 55.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.72 | -26.1% |
| FY2024 | $3.67 | +16.9% |
| FY2023 | $3.14 | -7.2% |
| FY2022 | $3.38 | -71.6% |
| FY2021 | $11.91 | +32.2% |
| FY2020 | $9.01 | -24.4% |
| FY2019 | $11.91 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026